Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Trials Regulation

ESMO-Public-Policy-Webinars-1000x250px-Clinical-Trials

ESMO Public Policy Webinars on the Clinical Trials Regulation

Date: 12 & 28 October 2021
Time: 13:00-14:00 CEST

The Clinical Trials Regulation, which was adopted in April 2014 and is foreseen to become applicable in January 2022, will introduce major changes to how clinical trials will be conducted in the EU, aiming to create a more favourable environment for medical research in Europe. Given the importance of this Regulation for research, including clinical trials in oncology, the European Society for Medical Oncology (ESMO) is dedicating 2 Public Policy Webinars to this topic:

  • The Clinical Trials Regulation and its impact on oncology held on Tuesday 12 October from 13:00-14:00 CEST
  • The Clinical Trials Regulation - Challenges and burdens affecting non-commercial research held on Thursday 28 October from 13:00-14:00 CEST

ESMO has been actively engaged in the process leading up to the adoption of the Clinical Trials Regulation and worked towards ensuring that medical oncologists are well informed about the impact of the new Regulation on clinical trials in oncology. Thus, given the implications of the Regulation for medical research in Europe, we feel that it is our responsibility to address this important topic, for the benefit of the oncology and health communities, and most importantly for the patients. 

The 1st webinar – held on 12 October 2021 – addressed how the Clinical Trials Regulation will affect clinical research in oncology. The agenda of this meeting can be accessed here.

  

The 2nd webinar – held on 28 October 2021 – brought together the perspectives of EU officials, clinical researchers, patients and medical oncologists on the Clinical Trials Regulation and how this legislation can impact existing challenges and burdens affecting academic and non-commercial clinical research in oncology. The agenda of this meeting is available here.

  

For further information, please do not hesitate to reach out to publicpolicy@esmo.org

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings